A multivitamin infusion prevents lipid peroxidation and improves transplantation performance  by Rabl, Hans et al.
Kidney International, Vol. 43 (1993), PP. 912—91 7
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A multivitamin infusion prevents lipid peroxidation and improves
transplantation performance. The objective of this study was to test the
hypothesis that ischemia reperfusion damage in kidney transplantation
is associated with lipid peroxidation and that inhibition of lipid perox-
idation by antioxidants improves the function of the transplanted
kidney. Lipid peroxidation was assessed by measuring the plasma
malonaldehyde content (as thiobarbituric acid reaction product) with
high-performance liquid chromatography. Kidney function was as-
sessed by plasma creatinine and creatinine clearance, Thirty patients of
an ongoing series were randomly selected into two groups, with 14
controls and 16 patients in the antioxidant therapy group. Therapy
consisted of two ampoules of Omnibionta (which contains vitamins C,
E, A and B complex) diluted in 500 ml physiological sodium chloride,
which was infused intravenously prior to reperfusion onset. No signif-
icant differences existed for the age of the patients in the control (43.00
9.86 years) and the therapy group (41.56 14.14 years) nor in the
kidney preservation time, which was 24.12 8.73 and 18.43 9.97
hours in the control and therapy group, respectively. The controls
showed a transient increase of plasma lipid peroxides as measured by
malonaldehyde with a peak one hour after onset of reperfusion.
Compared to the baseline value of 0.74 0.26 (mean SD) the one hour
malonaldehyde value increased to 1.46 0.22 nmol/ml (P < 0.001). In
the therapy group the plasma malonaldehyde level did not increase, but
slightly decreased by about 20% compared to the baseline value. The
difference of plasma malonaldehyde between the two groups one hour
after reperfusion onset was highly significant (P> 0.0001). Compared to
the control group, the therapy group had significantly lower creatinine
values at the postoperative days 1, 2, 3 and 4 (P <0.02, <0.006, <0.02
and <0.02, respectively). Also, the creatinine clearance rates were
significantly higher in the therapy group on days 1, 3 and 5 (P < 0.03,
<0.01 and <0.007). From day 6 on, no further improvement of
creatinine and creatinine clearance occurred in the therapy group and
no significant difference existed toward controls. This study shows that
antioxidative treatment by vitamins could be an important regimen in
the reduction of reperfusion damage.
Reactive oxygen species have been demonstrated by numer-
ous investigators [1—6] as one of the main sources of post-
ischemic injury. The kidneys appear to be relatively sensitive to
reperfusion injury [7]. The involvement of lipid peroxidation
induced by oxygen radicals has been strongly supported by
studies of Paller et a! [8, 9], although others have not been able
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to detect evidence for lipid peroxidation using similar experi-
mental models [10, 11]. Lipid peroxidation has usually been
assessed by measuring the amount of thiobarbituric acid reac-
tive substances (malonaldehyde) present in plasma or the
ischemic organ [12, 13].
Kidneys intended for transplantation are often subjected to
both warm ischemia before or at the time of removal and
reperfusion, and cold ischemia caused by preservation. While
cold ischemia results in only moderate renal damage, as most
metabolic functions are drastically reduced, warm ischemia
leads to variable damage during harvesting of the organ and
vascular reperfusion [14—171. During ischemia an accumulation
of xanthine oxidase and its substrate, hypoxanthine and xan-
thine have been demonstrated in several animal studies [16, 18,
19]. It has also been shown that allopurinol, a xanthine oxidase
inhibitor, has a protective effect against isehemia-induced renal
injury [7, 14, 20—221. A number of lipid mediators have been
proposed as modulators in isehemic/reperfusion injury. These
include vasodilatory prostaglandins [23] as well as the vasocon-
strictors thromboxane A2 [24], platelet activating factor [25]
and expoxyeicosatrienoic acids [26]. Nath and Paller observed
that animals chronically deficient in both selenium and a-toco-
pherol had greater functional impairment, histologic injury and
lipid peroxidation after ischemia [27], and Paller and Patten
found a readily apparent increase in H202 production in tubules
subjected to anoxia and reoxygenation [28].
If oxygen radicals and lipid peroxidation have a causative
role in reperfusion injury, then antioxidants should have a
protective effect. The main antioxidant in biological membranes
is a-tocopherol (vitamin E), which prevents lipid peroxidation
[reviewed in 29, 30]. A protective effect of vitamin E has been
reported for spinal cord injury [31], myocardial ischemia reper-
fusion injury [32] and ischemic rat liver cell injury [33]. Tak-
enaka [34] demonstrated a protective effect of a-tocopherol on
warm ischemic damage to rat kidney, where it led to an increase
of ATP synthesis after reflow following warm ischemia and a
lower serum creatinine level. This effect on metabolic function
was also accompanied by an increase in the survival rate of
ischemic rats. Yoshikawa et al [35] showed that gastric mucosal
injury induced by ischemia reperfusion is more severe in
vitamin E deficient rats as compared to vitamin E non-deficient
rats. Vitamin C is a water soluble antioxidant which can
detoxify oxygen radicals produced in the aqueous phase. In
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addition, vitamin C acts synergistically with vitamin E by
recycling it at the membrane-water interphase [36, 37]. 13-Car-
otene, known as provitamin A, is an efficient quencher for
singlet oxygen and a similar effect has been ascribed to retinol
and its derivatives [38].
We have previously shown in human patients that reperfu-
sion following kidney transplantation or limb revascularization
is associated with a strong lipid peroxidation process commenc-
ing shortly after onset of reperfusion and that it lasts for about
one to two hours [39]. We now show that in kidney transplan-
tation this lipid peroxidation can be prevented by intravenous
infusion of Omnibionta, a multi-vitamin preparation containing
antioxidants; this treatment also increases kidney viability and
function.
Methods
Patients
The group of patients comprised 30 subjects (22 male, 8
female) with a mean age of 42.23 years (range 21 to 63), who
were admitted to the Department of Urology at the University
of Graz for kidney transplantation. The surgical procedure of
kidney transplantation was performed according to the method
of Hinman [40]. Peripheral venous blood samples were taken
from each patient intraoperatively 30 minutes before and 1, 2, 3
and 4 hours and occasionally 6 to 18 hours after onset of
reperfusion of the transplanted kidney. Blood samples were
drawn without venous occlusion into EDTA-coated plastic
tubes, the plasma was separated by centrilugation and stored at
—20°C until analysis for lipid peroxidation (that is MDA-
thiobarbituric acid adduct determined by HPLC) for no longer
than 2 weeks. According to our experience, only minimal
increase of MDA-TBA occurs in EDTA supplemented plasma
during 2 weeks storage time at —20°C. Lee [41] found also nor
significant increase in plasma samples supplemented with
EDTA + GSH stored at 4°C for several weeks.
Out of the 30 patients in this study group 16 were randomly
selected for treatment with Omnibionta (therapy group),
whereas the remaining 14 patients not receiving Omnibionta but
also receiving kidney allograft are considered in this study as
controls. For treatment with Omnibionta, the content of two
ampoules, 10 ml each, was diluted with 500 ml physiological
sodium chloride solution. The infusion flask was covered by a
dark paper to protect against light. Immediately after taking the
first blood sample, that is, 30 minutes before onset of reperfu-
sion, the diluted Omnibionta solution was administered intra-
venously and most of the solutions were infused before reper-
fusion of the implanted kidney was started.
Lipid peroxidation was assessed by plasma MDA levels. The
collected and stored (—20°C) plasma samples were reacted with
thiobarbituric acid and the MDA-thiobarbituric acid adduct was
determined by HPLC as described by Wong et al [42], details of
this procedure were reported by us elsewhere [39].
Plasma creatinine levels were determined routinuously daily
up to day 9 after kidney transplantation according to [43];
creatinine clearance was determined according to [43] on days
1, 3, 5 and 7 after transplantation.
Omnibionta concentrate for infusion was from Merck (Darm-
stadt, Germany) and in Austria it has the registry number 13760.
According to the accompanying information sheet, one am-
poule (10 ml) contains: 5.5 mg retinol palmitate, 50.0 mg
thiaminchloride-hydrochloride, 10.0 mg riboflavin 5-phosphate
sodium, 100.0 mg nicotinamide, 25.0 mg dexpanthenol, 15.0 mg
pyridoxin-hydrochloride, 500.0 mg ascorbate, 5.0 mg a-toco-
pherol-acetate, 150.0 mg benzylalcohol, 500.0 mg polysorbate
80, 1.0 mg DL-a-tocopherol, 200.0 mg propylenglycol, 2500.0
mg glycerin 85%, 360.0 mg trometamol and 10 ml water added.
Statistical analysis was performed by the nonparametric
Mann-Whitney U-test.
Results
The study included 30 patients who underwent surgical
revascularization operations for kidney transplantation. All 14
subjects of the control group after one hour of reperfusion
showed a strong increase (P < 0.001) of plasma lipid peroxides
(as measured by MDA) compared to the initial baseline value.
The values returned to baseline again after about three to four
hours (Table 1). The statistical mean values measured 30
minutes prior to reperfusion and 1, 2, 3 and 4 hours after
reperfusion were 0.74, 1.46, 0.98, 0.91 and 0.77 nmol MDA/ml
plasma. The time course of the mean change of the MDA values
is shown in Figure 1. Occasionally measurements were also
performed at later time points. One and two days after trans-
plantation, the statistical mean was still at the baseline level.
After three and four days, however, a second onset of lipid
peroxidation appeared to occur, since six out of the seven
patients examined had increased MDA values again.
As can be seen from the data in Table 2, treatment with
Omnibionta inhibited the increase of MDA values. In 10 out of
16 patients, was after one hour of reperfusion the MDA equal to
or even lower than the initial value measured prior to reperfu-
sion. In the remaining six patients a weak increase of MDA was
observed, but this was minimal as compared to the increase
shown by the untreated control group (Table 1). The statistical
mean values measured in the therapy group 30 minutes prior to
reperfusion and 1, 2, 3 and 4 hours after reperfusion were 0.95,
0.86, 0.76, 0.76 and 0.74 nmol MDAJm1 plasma, respectively. In
the therapy group, statistically no significant difference exists
between baseline measured prior to reperfusion and the values
measured up to four hours after reperfusion. The time course of
the change of the MDA values in the therapy group in compar-
ison to the control group is shown in Figure 1. The difference of
the percentual change between the control and the therapy
group after one hour was statistically significant at P <0.0001.
In the therapy group, the MDA values remained more or less
constant between one and four hours after kidney transplanta-
tion. At the third and fourth day after transplantation, four out
of eight patients, who were further examined, showed increased
MDA values again.
The time profile of serum creatinine in both groups is shown
in Figure 2. Preoperative creatinine was nearly identical for the
control and therapy group (9.70 vs. 9.97 mgldl). In the control
group creatinine was rather stable over two days after surgery,
like the preoperative value, thereafter creatinine gradually
decreased reaching a value of about 5.5 mg/dl at day 7. In the
therapy group creatinine levels steadily decreased from the first
to the sixth day after transplantation. During this period the
creatinine was statistically significant (P < 0.006 to 0.02) lower
than in the control group. From day 7 on both groups had more
or less the same creatinine levels. That the therapy group had a
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Table 1. MDA values determined by HPLC in plasma of patients receiving kidney allograft (control group)
Patient
number
Age
years
Kidney MDA nmollrnl plasma
Preservation hr Solution —0.5 hr 1.0 hr 2.0 hr 3.0 hr 4,0 hr 1 day 2 day 3 day 4 day
1 42 18.3 EC 0.35 1.47 0.91 0.59 0.45 — — — —
2 35 28.0 HTK 0.9 1.11 0.76 0.90 0.83 0.74 1.01 — —
3 56 5.0 EC 0.9 1.29 1.37 1.22 0.83 0.93 1.15 1.43 1.11
4 33 29.2 HTK 0.32 1.40 0.38 0.53 0.48 0.51 0.37 0.48 0.80
5 33 28.2 EC 0.54 1.12 0.31 0.24 0.54 0.37 0.51 — —
6 27 17.4 EC 0.55 1.50 0.72 0.86 0.53 — — — 0.53
7 56 28.5 HTK 1,20 1.71 1.25 1.01 0.85 0.93 0.64 — —
8 35 12.2 UW 0.58 1,70 1.29 — — — — — —
9 38 22.0 UW 0.76 1.31 0.80 0.81 0.80 0.58 0.53 0.80 —
10 42 28.0 EC 0.63 1.28 1.40 1.19 1.08 0.85 1.31 — —
11 47 25.2 EC 1.09 1.84 1.22 1.17 1.28 — — — —
12 56 34.0 UW 0.90 1.51 1.01 1.04 0.75 1.34 1.29 2.07 0.98
13 52 38.5 UW 0.83 1.62 0.97 0.90 0.79 0.85 0.80 1.20 1.25
14 50 23.2 UW 0.90 1.69 1.42 1.39 0.87 0.94 0.88 1.30 1.23
Mean 43,00 24.12 0.74 1,46a 0.98 0.91 0.77 0.80 0.85 1.21 0.98
9.86 8.73 0.26 0.22 0.36 0.31 0.23 0.27 0.33 0.54 0.27
This is a supplemented version of Table I in ref. 39. Blood samples were taken 0.5 hr prior to reperfusion and 1, 2, 3, 4 hours and 1, 2, 3 and
4 days after beginning reperfusion. Dash (—) means not determined. Given is also the preservation time of the transplanted kidney and the solution,
in which it was kept prior transplantation. Abbreviations are: EC, Euro Collins; UW, University of Wisconsin; HTK, histidine-tryptophane-
ketoglutarate.
P < 0.001 compared to the 0.5 hr value
significantly better renal function during the first days after
transplantation than the control group, is also evident from the
creatinine clearance (Table 3). At the postoperative days 1, 3
and 5, the creatinine clearance rate was significantly improved
with P < 0.03 to 0.01 and 0.007, respectively. For example, at
days 1 and 3 the creatinine clearance was about threefold better
than in the control group.
Finally we have also examined whether statistical differences
existed between the control and therapy groups, regarding age
of the patients and duration of the storage time of the trans-
planted kidney. No statistical significant difference existed in
these two parameters. Also the type of preservation medium in
which the kidney was stored until transplantation had no effect
on MDA values, creatinine or creatinine clearance. Further
factors were compared which could lead to delayed allograft
function such as pre-missmatch, age and cause of death,
hypotension, administered pressors and serum creatinine in
donors, the number of transplantations and required dialysis in
recipients. A difference could only be computed for the serum
creatinine values in donors, which was significantly lower for
the control than for the therapy group (P < 0.018, mean SD
0.85 0.22 vs. 1.17 0.38 mg/dl).
Discussion
Reperfusion of an ischemic organ often results in severe
tissue damage, which is in part the consequence of reoxygen-
ation rather than the ischemic episode itself. Various lines of
research at the biochemical level and animal experiments
suggest that reoxygenation leads to an overproduction of dele-
terious oxygen radicals, which overwhelm the natural antioxi-
dant defense and impose an increased oxidative stress on the
reperfused organ and possibly on the whole body.
We have previously found [39] that surgical revascularization
operations in humans for limb salvage (28 cases) or kidney
transplantation (9 cases) shortly after start of reperfusion
causes a strong increase of lipid peroxidation, as measured by
plasma malonaldehyde. In continuation of this study further
measurements in additional five kidney recipients were made.
Table 1 contains all 14 controls examined so far, including some
additional information (preservation time and solutions) not
given in the cited reference [39]. Compared to the initial
baseline values (= 100%) the one hour MDA increased in
kidney transplantation to 197% (Fig. 1). In the case of limb
revascularization (individual data reported in [39]) the MDA
increased to 153%.
At the first glance, a mean increase of plasma peroxides from
0.74 to 1.46 nmol MDA/ml (Table 1) may appear to not be
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Fig. 1. Time course of the change of plasma MDA values measured in
kidney allograft recipients with (A, N = 16) and without (•, N = 14)
treatment with Omnibionta. MDA values were determined 0.5 hr prior
to start of reperfusion and at the indicated time points after begin of
reperfusion. The bars give the standard deviation. * P < 0.0001.
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Table 2. MDA values determined by HPLC in plasma of patients receiving kidney allograft and
treated by intravenous infusion of omnibionta (therapy group)
Patient
number
Age
years
Kidney MDA nmol/ml plasma
Preservation hr Solution —0.5 hr 1.0 hr 2.0 hr 3.0 hr 4.0 hr I day 2 day 3 day 4 day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
Mean
37
30
54
38
24
29
33
31
57
21
46
63
63
52
31
56
41.45
14.14
18.5
12.2
6.4
33.2
19.5
25.2
30.5
11.0
9.4
34.4
21.0
18.0
30.5
5.0
6.0
14.2
18.43
9.97
EC
UW
EC
UW
HTK
EC
UW
HTK
UW
EC
UW
EC
EC
UW
UW
EC
0.94
1.01
1.27
0.87
0.69
0.87
0.73
0.78
0.99
0.62
0.88
1.24
1.12
1.23
0.96
1.06
0.953
0.197
0.76
0.72
1.31
0.87
0.62
0.93
0.47
1.09
1.11
0.38
0.67
1.02
0.88
0.88
1.13
1.15
0.856
0.257
0.64
0.89
1.11
0.71
0.52
0.74
0.40
0.73
1.42
0.35
0.59
0.91
3.10
0.63
1.08
0.75
0.764
0.282
0.76
0.97
1.01
0.60
0.53
—
0.37
0.82
1.03
0.41
0.70
0.66
0.79
0.82
1.06
0.88
0.760
0.216
0.70
0.81
—
0.54
—
0.69
0.44
0.92
1.08
0.29
0.73
0.98
0.50
—
1.05
0.86
0.738
0.244
0.94
1.19
0.91
0.46
0.67
—
—
—
0.38
0,68
—
0.70
—
0.69
0.736
0.248
0.88
0.86
1.03
0.50
0.44
1.17
—
—
—
—
0.48
0.67
—
0.71
—
0.85
0.759
0.243
1.93
1.27
—
0.83
0.85
—
—
—
—
—
0.71
0.95
—
0.59
—
1.01
1.018
0.421
2.85
2.04
—
0.79
0.84
—
—
—
—
—
0.67
0.85
—
0.45
—
1.55
1.255
0.827
Abbreviatjons are in Table 1.
E
14
12
10
8
6
4
2
0
Reperfusiori start
Fig. 2. Time course of mean serum creatinine levels measured in
kidney allograft recipients with (A, N = 16) and without (•, N = 14)
treatment with Omnibionta. Values were measured preoperatively (0
day value) and at the indicated days after transplantation. The bars give
the standard deviation. * p < 0.02; ** P < 0.006.
dramatic. This increase should, however, be compared with
results from experimental animal studies. For example, in rats
poisoned with NiCI2, a compound inducing severe lipid perox-
idation in lung, liver and kidney, plasma MDA values (mea-
sured with the same assay as used in this study) increased from
1.4 to about 2,1 to 2.5 nmollml [42]. Thus a doubling of plasma
MDA, as seen in our kidney transplanted patients (Fig. 1, Table
1), indeed reflects a massive lipid peroxidation. It is reasonable
to assume that the plasma lipid peroxides stem from oxidatively
destroyed membranes of the perfused and reoxygenated kid-
ney. The rapid (within a few hours) return of plasma lipid
peroxides to the baseline level indicates that peroxidation in the
perfused kidney was a short-lasting and transient event. The
reason for that might be that lipid peroxidation was restricted to
certain foci (such as endothelial cells) where all susceptible
polyunsaturated fatty acids were quickly oxidized. Otherwise,
it could be that the plasma antioxidants entering into the kidney
from the reflowing blood halted the lipid peroxidation chain
reaction. From the few patients where plasma MDA values
have also been examined on the third and fourth days after
transplantation, the majority had higher values compared to the
first and second days after transplantation, suggesting a second
phase of lipid peroxidation. A similar observation of a late
increase of MDA was recently reported for patients with
myocardial infarction [44].
Alipurinol [2-22], superoxide dismutase or catalase have
been used with some success to reduce oxygen radical mediated
reperfusion injury [reviewed in 45]. Inhibition of lipid peroxi-
dation by low molecular weight lipid or water soluble antioxi-
dants has not received very much attention so far, although it
might be one of the most immediate approaches for therapeutic
treatment of humans.
From the time course of lipid peroxidation after kidney
transplantation (Fig. 1), it is clear that a successful prevention
will only be possible if the antioxidants are administered prior
to or immediately at the start of reperfusion. In kidney trans-
plantation, where rapid decisions have to be made, oral supple-
mentation prior to surgery is impracticable. We therefore opted
for an intravenous infusion during the operation itself, but
started it prior to the start of reperfusion of the transplanted
organ. In Austria, the only antioxidant preparation approved
and registered for intravenous infusion is Omnibionta; we have
therefore decided to examine its potentially beneficial effects in
kidney transplantation.
As can be seen in Table 2 and Figure 1, treatment with
Omnibionta fully prevented the reperfusion mediated rise of
Time, days aft:rtraspiatatiL
8
916 RabI et al: Multivitamins and transplantation
Table 3. Statistical comparison of control and therapy groups
Control (N = 14) Therapy (N = 16) Statistical difference
from control (P)Mean SD Range Mean SD Range
Age, years 43.0 9.86 27—56 41.6 14.1 21—63 NS
Preservation time of kidney, hr 24.12 8.73 5—38.5 18.4 9.9 5—34 NS
MDA, nmol/ml plasma
0.5 hr before reperfusion 0.74 0.26 0.32—1.20 0.95 0.19 0.62—1.24 0.03
1.0 hr after reperfusion 1.46 0.22 1.11—1.84 0.85 0.25 0.38—1.15 <0.0001
Creatinine mgldl serum
preoperative 9.7 2.16 (12) 5.3—13,8 9.9 2.2 (14) 6.2—13.9 NS
I day after transplantation 9.91 2.15 (14) 7.3—14.8 7.7 2.4 (16) 4.0—13.0 <0.02
2 days after transplantation 9.66 2.62 (14) 6. 1—13.9 6.5 3.8 (16) 2.0—16.3 <0.006
Creatinine clearance, mi/mm
I day after transplantation 12.13 6.24 (9) 2. 1—20.5 39.3 36.7 (11) 1.7—107 <0.03
3 days after transplantation 15.65 12.65 (9) 2. 1—36.9 41.7 23.3 (11) 10.7—82 <0.01
5 days after transplantation 26.3 19.5 (9) 1.6—54.6 59.5 21.7 (8) 16.4—79 <0.007
7 days after transplantation 32.15 29.15 (8) 1.2—80.0 58.8 23.0 (3) 32.3—74 NS
Control group was comprised of 14 patients and 16 patients were in the therapy group; if not all patients were examined, their number is given
in (brackets).
plasma lipid peroxides. Even more importantly, in the first four
to five days after transplantation the patients of the therapy
group had a much better renal function, as is clearly indicated
by the significantly (P < 0.02 to 0.006) lowered serum creatinine
levels (Fig. 2) and the three- to fourfold better (P < 0.007 to
0.01) creatinine clearance rate. This finding suggests, but of
course does not prove, a causal relationship between lipid
peroxidation and renal reperfusion injury, or in other words,
that inhibition of lipid peroxidation resulted in improved viabil-
ity and function of the transplanted kidney. After about the fifth
postoperative day the renal performance of the therapy and
control groups approached each other, and from thereon no
statistically significant difference between the two groups ex-
isted.
Can the effects of Omnibionta indeed be ascribed to an
antioxidant effect, and if so, to which one of the antioxidants?
This question is difficult to answer, since Omnibionta contains
additional to the antioxidant vitamins, that is, ascorbate (vita-
min C), a-tocopherol (vitamin E) and retinol (vitamin A), and
several components of the vitamin B-complex (vitamin B1,
vitamin B2, niacin and panthotenate). The administered dose (2
ampoules) of the individual vitamins corresponds to the x-fold
of the daily requirement recommended by the German Society
for Nutrition [461: ascorbate 13x, vitamin E 1 .Ox, vitamin A 6x,
vitamin B1 70x, vitamin B2 8x, niacin lix, vitamin B6 16x and
panthotenate 6x. With the simplified assumption that the an-
tioxidant vitamins distributed during infusion solely in the blood
serum compartment, they reached there peak concentrations of
about 2.3 m (ascorbate), 10 M (vitamin E) and 8 jsM (vitamin
A), which has to be compared with the estimated normal levels
(not measured) of approximately 40 M ascorbate, 20 M
vitamin E and 1 LM vitamin A. This rough estimation suggests
that the infused ascorbate plays a major role in inhibiting lipid
peroxidation. Of all the antioxidants ascorbate had the stron-
gest relative increase (about 50-fold) and reached the highest
concentration (about 2.3 mM) in plasma. The infusion mediated
change of the endogenous levels of vitamin E and A was much
less than that of vitamin C. The inhibitory effects of ascorbate
on lipid peroxidation are well documented: it essentially pro-
tects vitamin E, the primary membrane antioxidant, against
destruction by free radicals. Infusion of a high concentration of
ascorbate presumably prevents lipid peroxidation by improving
the recycling of vitamin E. The other components of the vitamin
B complex could have an important auxiliary function in
stimulating metabolic pathways providing reducing equivalents
(NADPH) necessary to keep glutathione and ascorbate in the
reduced form. That ischemia reperfusion shifts the GSH/GSSG
equilibrium to the side of GSSG has been reported by Ferrari et
al [47].
Finally, it should be mentioned that ischemia reperfusion
causes the production of different humoral mediators, including
thromboxane A2, prostaglandins and leukotrienes. Thrombox-
ane A2 is a potent vasoconstrictor and platelet proaggregator,
whose level increases after ischemia in different organs. A
blockage of thromboxane A2 formation has been found to
improve kidney performance after ischemia [45]. According to
Lands, Kuimacz and Marshall [48], plasma and tissue "perox-
ide tone" is an important factor in regulating eicosanoid ho-
meostasis. A normal peroxide tone, as achieved by treatment
with Omnibionta, may therefore also contribute to better the
renal vascular function.
Acknowledgment
The work of the Institute of Biochemistry has been supported by the
Association for International Cancer Research.
Reprint requests to Dr. Hans Rabl, Division of General Surgery,
University of Graz, Auenbruggerplatz 29, A-8036 Graz, Austria.
References
I. BAKaR GL, C0RRY RJ, AUTOR AP: Oxygen free radical induced
damage in kidneys subjected to warm ischemia and reperfusion:
Protective effect of superoxide dismutase. Ann Surg 202:628—641,
1985
2. BIRD JE, EVAN AP, PETERSON OW, BLANTZ RC: Early events in
ischemic renal failure in the rat: Effects of antioxidant therapy.
Kidney mt 35:1282—1289, 1989
3. HANSSON R, JoNssoN 0, LUNDSTAM S, PETTERSSON 5, SCHER-
STaN T, WALDENSTROM J: Effects of free radical scavengers on
renal circulation after ischemia in the rabbit. Clin Sci 65:605—610,
1983
Rabi et a!: Multivitamins and transplantation 917
4. LINAS SL, WHITTENBURG D, REPINE JEt 02 metabolites cause
reperfusion injury after short but not prolonged renal ischemia. AmJ Physiol 253 (Renal Fluid Electrol Physiol 22):F685—F691, 1987
5. OURIEL K, SMEDICA NG, RICOTrA JJ: Protection of the kidney
after temporary ischemia: Free radical scavengers. J Vasc Surg
2:49—53, 1985
6. PALLER MS, HOIDAL JR, FERRIS TF: Oxygen free radicals in
ischemic acute renal failure in the rat. J Clin Invest 74:1156—1164,
1984
7. RATYCH RE, BULKLEY GB, WILLIAMS GM: Ischemialreperfusion
injury in the kidney, in Transplantation: Approaches to Graft
Rejection, edited by MERYMAN HT, New York, Alan R. Liss Inc.,
1986, pp. 263—289
8. PALLERMS, H0IDAL JR, FERRIS TF: Oxygen radicals in ischemic
acute renal failure in the rat. J Clin Invest 74:1156—1 164, 1984
9. PALLER MS. HEDLUND BE: Role of iron in postischemic injury in
the rat. Kidney mt 34:474—480, 1988
10. McCoY RN, HILL KE, AYON MA, STEIN JH, BURKE RF: Oxidant
stress following renal ischemia: Changes in the glutathione redox
ratio. Kidney Int 33:812—817, 1988
11. BIRD JE, MILHOAN K, WILSON CB, YOUNG SG, MUNDAY CA,
PARTHASARATHY 5, BLANTZ RC: Ischemic acute renal failure and
antioxidant therapy in the rat. J Clin Invest 81:1630—1638, 1988
12. YAGI K: Assay for serum lipid peroxide level and its clinical
significance, in Lipidperoxides in Biology and Medicine, edited by
YAGI K, New York, Academic Press, 1982, pp. 223—242
13. SCHIMKE I, PAPIES B: Some methodological aspects of the estima-
tion of thiobarbituric acid-reactive substances in plasma. Z Med
Lab Diagn 27:71—75, 1986
14. PARKS DA, BULKLEY GB, GRANGER DN: Role of oxygen free
radicals in shock, ischemia and organ preservation. Surgery 94:
428—431, 1983
15. BULKLEY GB: The role of oxygen free radicals in human disease
processes. Surgery 94(3):407—41 1, 1983
16. K0YAMA I, BULKLEYGB, WILLIAMS GM: The role of oxygen free
radicals in mediating the reperfusion injury of cold-preserved
ischemic kidneys. Transplantation 40:590—595, 1985
17. STEINER MG, BABBS CF: Hydroxyl radical generation by post-
ischemic rat kidney slices in vitro. Free Radic Biol Med 9 (l):67—77,
1990
18. HANSSON R, GUSTAFSSON B, JONSSON 0: Effect of xanthine
oxidase inhibition on renal circulation after ischemia. Transplant
Proc 14:51—58, 1985
19. MILLER WL, THOMAS RA, BERNE M: Adenosine production in the
ischemic kidney. Circ Res 43:390—397, 1978
20. VASKO KA, DEWALL RA, RILEY AM: Effect of allopurinol in renal
ischemia. Surgery 71:787—790, 1972
21. TOLEDO-PEREYRA LH, SIMMONS RL, NAJARIAN JS: Effect of
allopurinol on the preservation of ischemic kidneys perfused with
plasma or plasma substitutes. Ann Surg 180:780—782, 1974
22. HO5HINO T, MALEY WR, WILLIAMS GM, BULKLEY GB: The effect
of oxypunnol in preventing free radical-mediated reperfusion injury
in cold preserved kidneys, in Proc 4th Biennial General Meeting
SFRR, edited by HAYASHI 0, NIKI E, KONDO M, YOSHIKAWA T,
Basel, Elsevier Science Publishers, 1989, pp. 531—534
23. HERBACZYNSKA K, VANE JR: Contribution of intrarenal generation
of prostaglandins to autoregulation of blood flow in the dog. Circ
Res 23:428—436, 1973
24. HA5SID A, KONIECZKOWSKI M, DUNN MJ: Prostaglandinsynthesis
in isolated rat kidney glomeruli. Proc NatI Acad Sci USA 76:1155—
1163, 1979
25. SCHERF H, NIES AS, SCHWERTSCHLAG M, HUGHES M: Hemody-
namic effects of platelet activating factor in the dog kidney in vivo.
Hypertension 8:737—741, 1986
26. TAKAHA5HI K, CAPDEVILA J, KARARA A, FALCK JR, JACOBSEN
HR, BADR KR: Cytochrome P-450 arachidonate metabolites in rat
kidney: Characterization and hemodynamic responses. Am J Phys-
iol 258:F781—F789, 1990
27. NATH KA, PALLER MS: Dietary deficiency of antioxidants exacer-
bates ischemic injury in the rat kidney. Kidney mt 38:1109—1117,
1990
28. PALLER MS. PATTEN M: Hydrogen peroxide and ischemic renal
injury: Effect of catalase inhibition. Free Rad Biol Med 10:29—34,
1991
29. BURTON GW, ING0LD KU: Vitamin E as an in vitro and in vivo
antioxidant. Ann NY Acad Sci 570:7—21, 1989
30. DIPLOCK AT: Antioxidant nutrients and disease prevention: An
overview. Am J Clin Nutr 53:189S—193S, 1991
31. IwAsA K, IKATA T, FUKUZAWA K: Protective effect of vitamin E
on spinal cord injury by compression and concurrent lipid peroxi-
dation. Free Rad Biol Med 6:599—606, 1989
32. JANERO DR: Therapeutic potential of vitamin E against myocardial
ischemic reperfusion injury. Free Rad Biol Med 10:315—324, 1991
33. MARUBAYASHI 5, Doi K, OcHI K, KAWASAKI T: Role of free
radicals in ischemic rat liver cell injury: Prevention of damage by
alpha-tocopherol administration. Surgery 99 (2): 184-191, 1985
34. TAKENAKA M, TATSUKAWA Y, D0HI K, EZAKI H, MATSUKAWA K,
KAWASAKI T: Protective effects of alpha-tocopherol and coenzyme
Q10 on warm ischemic damages of the rat kidney. Transplant 32
(2):137—141, 1981
35. YOSHIKAWA T, YASUDA M, UEDA S, NAITO Y, TANIGAWA T,
OYAMADA H, KONDO M: Vitamin E in gastric mucosal injury
induced by ischemia-reperfusion. Am J Clin Nutr 53:2lOS—214S,
1991
36. MOROZKINA TS, GRII4KO IV, SUKOLINSKII VN, POLYAKOVA ZI,
OLETSKII El: The efficacy of the combined use of lipid- and
water-soluble bioantioxidants (vitamins E, A and C). Vopr Pitan
(3):56—60, 1989
37. TROUT DL: Vitamin C and cardiovascular risk factors. Am J Clin
Nutr 53:322S—325S, 1991
38. WEFERS H, SIEs H: Antioxidant defense: vitamins E and C, and
beta-carotene. UCLA Symposium on Molecular Cellular Biology,
New Series, Oxy-Radicals Mo! Biol Pathol 82:481—90, 1988
39. RABL H, KHOSCHSORUR G, COLOMBO T, TATZBER F, ESTERBAUER
H: Human plasma lipid peroxide levels show a strong transient
increase after successful revascularisation operations. Free Rad
BiolMed 13:281—288, 1992
40. HINMAN F JR: Renal Transplant Recipient, in Atlas of Urologic
Surgery, New York, W.B. Saunders Company, Section 17, 1990,
pp. 746—752
41. LEE DM: Malondialdehyde formation in stored plasma. Biochem
Biophys Res Commun 95:1663—1672, 1980
42. WONG STEVEN HY, KNIGHT JA, HOPFER SM, ZAHARIA 0, LEACH
CHN JR, SUNDERMAN FW JR: Lipoperoxides in plasma as mea-
sured by liquid-chromatographic separation of malondialdehyde-
thiobarbituric acid adduct. Clin Chem 33 (2):214—220, 1987
43. APPLE F: Creatinine clearance: Enzymatic vs. Jaffè determinations
of creatinine in plasma and urine. Clin Chem 32:388, 1986
44. DAVIES SW, RANJADAYALAN K, WIcKEN5 DG, WINTERTON SJ,
MAHY I, DORMANDY DL, UMACHANDRAN V, TIMMIS AD: Gran-
ulocyte activation and free radical activity following thrombolysis
of myocardial infarction. Eur Heart J 13 (abstract, Supplement)
903:901, 1992
45. OMAR B, MCCORD J, DOWNEY J: Ischemia-reperfusion, in Oxida-
tive Stress: Oxidants and Antioxidants, edited by H SIES, New
York, Academic Press, 1991, pp. 493—527
46. Deutsche Gesellschaft für Ernahrung, Empfehlung für die Nährst-
offzufuhr, 4. Aufi., Um schau Verlag, Frankfurt, 1985
47. FERRARI R, CEc0NI 5, CURELLO 5, CARGNONI A, PASINI E, DE
GIULI F, ALBERTINI A: Role of oxygen free radicals in ischemic
and reperfused myocardium. Am J Clin Nutr 53:215S—222S, 1991
48. LANDS WEM, KULMACZ RJ, MARSHALL PJ: Lipid peroxide ac-
tions in the regulation of prostaglandin biosynthesis, in Free
Radicals in Biology (vol. VI) edited by WA PRYOR, Orlando, San
Diego, Academic Press, 1984
